Cooley, Latham Steer Biotech Startup's Upsized $161M IPO
Shares of startup drug developer Structure Therapeutics Inc. soared 73% in trading Friday following an upsized $161 million initial public offering, guided by Cooley LLP and underwriters counsel Latham & Watkins...To view the full article, register now.
Already a subscriber? Click here to view full article